Exercise-Driven Comprehensive Recovery: Pulmonary Rehabilitation's Impact on Lung Function, Mechanics, and Immune Response in Post-COVID-19 Patients.

IF 3.4 Q2 INFECTIOUS DISEASES Infectious Disease Reports Pub Date : 2025-01-03 DOI:10.3390/idr17010001
Maysa Alves Rodrigues Brandao-Rangel, Boris Brill, Guilherme Eustáquio Furtado, Catharine Cássia Lanna Freitas-Rolim, Anamei Silva-Reis, Victor Hugo Souza-Palmeira, Renilson Moraes-Ferreira, Vanessa Lopes-Silva, Regiane Albertini, Wendel Simões Fernandes, Sérgio César Ferreira, Ricardo César Alves Ferreira, Jose Roberto Mateus-Silva, Carlos Rocha Oliveira, Claudio Ricardo Frison, Rodolfo P Vieira
{"title":"Exercise-Driven Comprehensive Recovery: Pulmonary Rehabilitation's Impact on Lung Function, Mechanics, and Immune Response in Post-COVID-19 Patients.","authors":"Maysa Alves Rodrigues Brandao-Rangel, Boris Brill, Guilherme Eustáquio Furtado, Catharine Cássia Lanna Freitas-Rolim, Anamei Silva-Reis, Victor Hugo Souza-Palmeira, Renilson Moraes-Ferreira, Vanessa Lopes-Silva, Regiane Albertini, Wendel Simões Fernandes, Sérgio César Ferreira, Ricardo César Alves Ferreira, Jose Roberto Mateus-Silva, Carlos Rocha Oliveira, Claudio Ricardo Frison, Rodolfo P Vieira","doi":"10.3390/idr17010001","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> We sought to evaluate the effects of a 12-week pulmonary rehabilitation (PR) program on lung function, mechanics, as well as pulmonary and systemic inflammation in a cohort of 33 individuals with moderate to severe post-COVID-19. <b>Material and Methods</b>: The pulmonary rehabilitation (PR) program employed a combination of aerobic and resistance exercises. Thirty minutes of treadmill training at 75% of the maximum heart rate, combined with 30 min resistance training consisting of 75% of one maximum repetition, three times a week throughout 12 weeks. <b>Results</b>: PR improved the lung function, FVC (<i>p</i> < 0.02), FEV1 (<i>p</i> < 0.02), FEV1/FVC (<i>p</i> < 0.01), MEF25% (<i>p</i> < 0.006), MEF50% (<i>p</i> < 0.03), and MEF75% (<i>p</i> < 0.02). PR also positively influenced lung mechanics, reducing respiratory impedance (Z5Hz, <i>p</i> < 0.03), respiratory reactance (X5Hz, <i>p</i> < 0.01), resistance of the entire respiratory system (R5Hz, <i>p</i> < 0.03), central airway resistance (RCentral, <i>p</i> < 0.03), and peripheral airway resistance (RPeripheral, <i>p</i> < 0.02). Moreover, muscle strength gains were evident, with significant improvements observed in hand grip strength for both the right (<i>p</i> < 0.02) and left (<i>p</i> < 0.01) hands, as well as maximal inspiratory (<i>p</i> < 0.02) and expiratory (<i>p</i> < 0.03) pressures. Additionally, PR exhibited anti-inflammatory effects by reducing the pro-inflammatory cytokines IL-1β (<i>p</i> < 0.0001) and IL-6 (<i>p</i> < 0.0001) and increasing the anti-inflammatory IL-1RA (<i>p</i> < 0.0004) and IL-10 (<i>p</i> < 0.003) and anti-viral IFN-γ (<i>p</i> < 0.0002) and IFN-β (<i>p</i> < 0.008) cytokines in breath condensate and serum samples. <b>Conclusions</b>: Collectively, these findings highlight the effectiveness of PR in ameliorating COVID-19 sequel across respiratory system, skeletal muscle, and immune responses. This highlights its promising potential as a therapeutic intervention for individuals recovering from COVID-19.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"17 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755557/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Disease Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/idr17010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: We sought to evaluate the effects of a 12-week pulmonary rehabilitation (PR) program on lung function, mechanics, as well as pulmonary and systemic inflammation in a cohort of 33 individuals with moderate to severe post-COVID-19. Material and Methods: The pulmonary rehabilitation (PR) program employed a combination of aerobic and resistance exercises. Thirty minutes of treadmill training at 75% of the maximum heart rate, combined with 30 min resistance training consisting of 75% of one maximum repetition, three times a week throughout 12 weeks. Results: PR improved the lung function, FVC (p < 0.02), FEV1 (p < 0.02), FEV1/FVC (p < 0.01), MEF25% (p < 0.006), MEF50% (p < 0.03), and MEF75% (p < 0.02). PR also positively influenced lung mechanics, reducing respiratory impedance (Z5Hz, p < 0.03), respiratory reactance (X5Hz, p < 0.01), resistance of the entire respiratory system (R5Hz, p < 0.03), central airway resistance (RCentral, p < 0.03), and peripheral airway resistance (RPeripheral, p < 0.02). Moreover, muscle strength gains were evident, with significant improvements observed in hand grip strength for both the right (p < 0.02) and left (p < 0.01) hands, as well as maximal inspiratory (p < 0.02) and expiratory (p < 0.03) pressures. Additionally, PR exhibited anti-inflammatory effects by reducing the pro-inflammatory cytokines IL-1β (p < 0.0001) and IL-6 (p < 0.0001) and increasing the anti-inflammatory IL-1RA (p < 0.0004) and IL-10 (p < 0.003) and anti-viral IFN-γ (p < 0.0002) and IFN-β (p < 0.008) cytokines in breath condensate and serum samples. Conclusions: Collectively, these findings highlight the effectiveness of PR in ameliorating COVID-19 sequel across respiratory system, skeletal muscle, and immune responses. This highlights its promising potential as a therapeutic intervention for individuals recovering from COVID-19.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Infectious Disease Reports
Infectious Disease Reports INFECTIOUS DISEASES-
CiteScore
5.10
自引率
0.00%
发文量
82
审稿时长
11 weeks
期刊最新文献
Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent Use. Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling. Etiological Insights and the Role of Individual Factors in Infectious Spondylodiscitis. Treatment of Onychomycosis and the Drug-Drug Interactions in Patients with Diabetes Mellitus and Diabetic Foot Syndrome: A Systematic Review. Addressing Vaccine Hesitancy: Validating the PACV Survey for Croatian Parents.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1